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background: There is strong evidence for the association of high blood pressure (BP) with depressed renal function and that BP reduction delays 
progression of chronic kidney disease (CKD). Randomized trials in CKD patients found no significant relationship between intense BP control and 
glomerular filtration rate (GFR) decline. However, the relationship of GFR to lower achieved systolic BP (SBP) in hypertensive patients without CKD is 
unclear.
methods: Baseline and yearly GFR and change in GFR were examined in relation to average in-treatment SBP in 8778 hypertensive patients with 
ECG LVH and baseline creatinine measurements, randomized to losartan- vs atenolol-based treatment. GFR was estimated using the Modification of 
Diet in Renal Disease study equation. Patients with average in-treatment SBP ≤130 mm Hg (lowest quintile at last measurement) and SBP between 
131 and 141, were compared with patients with average SBP ≥142 (median SBP at last measurement).
results: Compared with average SBP ≥142, average SBP ≤130 was associated with lower mean GFR at baseline and each year of the study in 
multivariate analyses (Table). However, from year-2 on, the decrease in GFR from baseline to each year of the study was significantly lower among 
patients with SBP ≤130 and greatest when SBP ≥142. 
conclusions: Average in-treatment SBP ≤130 is associated with a lower GFR but with a slower reduction in GFR during 4 years follow-up in 
hypertensive patients with ECG LVH, independent of other possible risk factors for decreased GFR.
 
